Congress Accuses Ruling Coalition of Complicity in Puducherry Counterfeit Drug Scandal

In a sharp escalation of political rhetoric ahead of the 2026 Assembly elections, senior Congress leader Pawan Khera has leveled grave allegations against the incumbent AINRC-BJP coalition government in Puducherry. Khera asserted that the ruling alliance has committed a 'sin' by allegedly permitting the manufacture and distribution of counterfeit pharmaceuticals within the Union Territory. This accusation strikes at the core of public health governance and regulatory oversight. The Congress leader framed the issue as a fundamental failure of administration, vowing that a future Congress government would prioritize governance and enact sweeping changes. His statement included a pledge to prosecute not only the direct perpetrators but also those in power who enabled such activities, signaling an intent to pursue accountability across the political and bureaucratic chain. The allegation, if substantiated, represents a significant breach of public trust with potential national security implications given the critical nature of medical supply chains. This development positions public health integrity as a central electoral battleground in Puducherry, with the opposition seeking to frame the incumbent regime as negligent on a matter of vital citizen welfare.